Millennium Management
QTTB icon

Millennium Management’s Q32 Bio QTTB Stock Holding History

Millennium Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,268
Closed -$170K – 6497
2025
Q4 		$170K Sell
51,268
-53,504
-51% -$151K ﹤0.01% 5513
2025
Q3 		$207K Sell
104,772
-25,607
-20% -$49.2K ﹤0.01% 5529
2025
Q2 		$194K Buy
+130,379
New +$222K ﹤0.01% 5373
2025
Q1 		– Sell
-10,725
Closed -$36.9K – 6501
2024
Q4 		$36.9K Sell
10,725
-89,618
-89% -$2.83M ﹤0.01% 5633
2024
Q3 		$4.48M Buy
+100,343
New +$3.69M ﹤0.01% 2938
2024
Q1 		– Sell
-960
Closed -$10.5K – 6739
2023
Q4 		$10.5K Sell
960
-5,622
-85% -$82.2K ﹤0.01% 5734
2023
Q3 		$139K Sell
6,582
-3,530
-35% -$72K ﹤0.01% 5244
2023
Q2 		$161K Sell
10,112
-1,537
-13% -$27.6K ﹤0.01% 5201
2023
Q1 		$216K Sell
11,649
-1,740
-13% -$43.3K ﹤0.01% 5129
2022
Q4 		$304K Sell
13,389
-12,138
-48% -$322K ﹤0.01% 5098
2022
Q3 		$740K Sell
25,527
-14,582
-36% -$595K ﹤0.01% 4598
2022
Q2 		$1.42M Buy
+40,109
New +$1.37M ﹤0.01% 4042
2022
Q1 		– Sell
-11,620
Closed -$761K – 7590
2021
Q4 		$761K Buy
11,620
+4,586
+65% +$445K ﹤0.01% 4668
2021
Q3 		$996K Sell
7,034
-8,960
-56% -$1.14M ﹤0.01% 4693
2021
Q2 		$2.09M Buy
15,994
+2,190
+16% +$273K ﹤0.01% 3901
2021
Q1 		$2.34M Buy
13,804
+4,637
+51% +$976K ﹤0.01% 3385
2020
Q4 		$1.86M Buy
9,167
+1,850
+25% +$358K ﹤0.01% 3294
2020
Q3 		$1.41K Sell
7,317
-3,904
-35% -$875K ﹤0.01% 2875
2020
Q2 		$3.07M Buy
11,221
+9,838
+711% +$2.62M ﹤0.01% 2199
2020
Q1 		$387K Sell
1,383
-1,776
-56% -$544K ﹤0.01% 3030
2019
Q4 		$1.18M Buy
+3,159
New +$905K ﹤0.01% 2933
2019
Q3 		– Sell
-1,153
Closed -$406K – 4620
2019
Q2 		$406K Buy
+1,153
New +$453K ﹤0.01% 3364
2018
Q2 		– Sell
-5,051
Closed -$1.7M – 4243
2018
Q1 		$1.7M Buy
+5,051
New +$1.7M ﹤0.01% 2414

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management's QTTB Position: Q1 2026 in Review

Millennium Management sold out of Q32 Bio (QTTB) in Q1 2026, closing a stake of 51,268 shares — an estimated $170K sold.

Millennium Management first reported a position in QTTB in Q1 2018 and held it in 23 quarters. The position peaked at $4.48M in Q3 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Millennium Management reported no remaining Q32 Bio position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 51,268 Q32 Bio shares in Q1 2026, an estimated $170K.
  • Millennium Management first reported a position in Q32 Bio in Q1 2018 and held it in 23 quarters.
  • Millennium Management's Q32 Bio position peaked at $4.48M in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.